Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Zhu

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|November 8, 2023
Temporal dynamics of attitude decisions: A test of the iterative reprocessing model using event-related potentialsRay Johnson, Heather Henkell, Elizabeth J Simon, et al.
Clinical Drug Investigation|July 1, 2016
Impact of Formulation on the Pharmacokinetics of Dutasteride: Results from Two Phase I StudiesMichael Fossler, John Zhu, Claus Roehrborn, et al.
The Journal of Antimicrobial Chemotherapy|April 6, 2013
Safety, tolerability and pharmacokinetics of repeat dosing of the antibiotic GSK1322322, a peptide deformylase inhibitor: a randomized placebo-controlled studyOdin J Naderer, Etienne Dumont, John Zhu, et al.
Journal of Clinical Pharmacology|August 3, 2013
Safety, tolerability, and pharmacokinetics of oral and intravenous administration of GSK1322322, a peptide deformylase inhibitorOdin J Naderer, Lori S Jones, John Zhu, et al.
Antimicrobial Agents and Chemotherapy|February 14, 2013
Single-dose safety, tolerability, and pharmacokinetics of the antibiotic GSK1322322, a novel peptide deformylase inhibitorOdin J Naderer, Etienne Dumont, John Zhu, et al.
Antimicrobial Agents and Chemotherapy|March 27, 2013
Effect of H2 blockade and food on single-dose pharmacokinetics of GSK1322322, a peptide deformylase inhibitor antibacterialOdin J Naderer, Etienne Dumont, John Zhu, et al.
Clinical Pharmacology in Drug Development|January 28, 2017
Bioequivalence Studies of a Reformulated Dutasteride and Tamsulosin Hydrochloride Combination Capsule and a Commercially Available FormulationRenee Kurczewski, Chet Bowen, David Collins, et al.
Respiration; International Review of Thoracic Diseases|March 31, 2026
Rates of nodal-upstaging following Systematic Endobronchial Ultrasound Lymph Node Staging in Non-Metastatic Non-Small Cell Lung Cancer: A Systematic Review and Meta-AnalysisJohn Zhu, Matthew Bricknell, Jack M Watson, et al.
Clinical Pharmacology in Drug Development|January 17, 2019
A Phase 1 Randomized, Placebo-Controlled Trial With a Topical Inhibitor of Stearoyl-Coenzyme A Desaturase 1 Under Occluded and Nonoccluded ConditionsRichard A Brigandi, John Zhu, Amy A Murnane, et al.
Clinical Pharmacology in Drug Development|June 23, 2015
The Effect of Food and Formulation on the Pharmacokinetics, Safety, and Tolerability of GSK1322322 in Healthy VolunteersOdin Naderer, Lori S Jones, John Zhu, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|November 8, 2023
Temporal dynamics of attitude decisions: A test of the iterative reprocessing model using event-related potentialsRay Johnson, Heather Henkell, Elizabeth J Simon, et al.
Clinical Drug Investigation|July 1, 2016
Impact of Formulation on the Pharmacokinetics of Dutasteride: Results from Two Phase I StudiesMichael Fossler, John Zhu, Claus Roehrborn, et al.
The Journal of Antimicrobial Chemotherapy|April 6, 2013
Safety, tolerability and pharmacokinetics of repeat dosing of the antibiotic GSK1322322, a peptide deformylase inhibitor: a randomized placebo-controlled studyOdin J Naderer, Etienne Dumont, John Zhu, et al.
Journal of Clinical Pharmacology|August 3, 2013
Safety, tolerability, and pharmacokinetics of oral and intravenous administration of GSK1322322, a peptide deformylase inhibitorOdin J Naderer, Lori S Jones, John Zhu, et al.
Antimicrobial Agents and Chemotherapy|February 14, 2013
Single-dose safety, tolerability, and pharmacokinetics of the antibiotic GSK1322322, a novel peptide deformylase inhibitorOdin J Naderer, Etienne Dumont, John Zhu, et al.
Antimicrobial Agents and Chemotherapy|March 27, 2013
Effect of H2 blockade and food on single-dose pharmacokinetics of GSK1322322, a peptide deformylase inhibitor antibacterialOdin J Naderer, Etienne Dumont, John Zhu, et al.
Clinical Pharmacology in Drug Development|January 28, 2017
Bioequivalence Studies of a Reformulated Dutasteride and Tamsulosin Hydrochloride Combination Capsule and a Commercially Available FormulationRenee Kurczewski, Chet Bowen, David Collins, et al.
Respiration; International Review of Thoracic Diseases|March 31, 2026
Rates of nodal-upstaging following Systematic Endobronchial Ultrasound Lymph Node Staging in Non-Metastatic Non-Small Cell Lung Cancer: A Systematic Review and Meta-AnalysisJohn Zhu, Matthew Bricknell, Jack M Watson, et al.
Clinical Pharmacology in Drug Development|January 17, 2019
A Phase 1 Randomized, Placebo-Controlled Trial With a Topical Inhibitor of Stearoyl-Coenzyme A Desaturase 1 Under Occluded and Nonoccluded ConditionsRichard A Brigandi, John Zhu, Amy A Murnane, et al.
Clinical Pharmacology in Drug Development|June 23, 2015
The Effect of Food and Formulation on the Pharmacokinetics, Safety, and Tolerability of GSK1322322 in Healthy VolunteersOdin Naderer, Lori S Jones, John Zhu, et al.
Pageof 4